Get the Stockscreener App
1.43
2.14%
0.03
After Hours:
1.48
0.05
+3.50%
Omniab Inc stock is traded at $1.43, with a volume of 567.08K.
It is up +2.14% in the last 24 hours and down -7.14% over the past month.
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
See More
Previous Close:
$1.40
Open:
$1.4
24h Volume:
567.08K
Relative Volume:
1.40
Market Cap:
$207.31M
Revenue:
$18.67M
Net Income/Loss:
$-64.78M
P/E Ratio:
-2.4788
EPS:
-0.5769
Net Cash Flow:
$-37.02M
1W Performance:
+5.15%
1M Performance:
-7.14%
6M Performance:
+3.62%
1Y Performance:
-7.74%
1-Day Range:
$1.3502
$1.455
1-Week Range:
$1.35
$1.455
52-Week Range:
$1.22
$2.295
Omniab Inc Stock (OABI) Company Profile
Name
Omniab Inc
Sector
Industry
Phone
510-250-7800
Address
5980 HORTON STREET, EMERYVILLE
Compare OABI vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
1.43 | 202.96M | 18.67M | -64.78M | -37.02M | -0.5769 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Apr-21-23 | Initiated | The Benchmark Company | Buy |
| Apr-13-23 | Initiated | Craig Hallum | Buy |
| Feb-22-23 | Initiated | Cowen | Outperform |
| Feb-13-23 | Initiated | H.C. Wainwright | Buy |
| Dec-20-22 | Initiated | Truist | Buy |
| Dec-16-22 | Initiated | Credit Suisse | Outperform |
| Nov-29-22 | Initiated | SVB Leerink | Outperform |
| Nov-28-22 | Initiated | Stifel | Buy |
View All
Omniab Inc Stock (OABI) Latest News
OABI | OmniAb, Inc. Common Stock Executive Compensation - Quiver Quantitative
OmniAb (OABI) Expected to Announce Earnings on Thursday - MarketBeat
Insider Buyers At OmniAb Likely Disappointed With 13% Slide - simplywall.st
OmniAb (NASDAQ:OABI) Shares Down 2.8%Here's What Happened - MarketBeat
OABI Stock Price, Quote & Chart | OMNIAB INC (NASDAQ:OABI) - ChartMill
OmniAb to Participate in Three Upcoming Investor Conferences - marketscreener.com
OmniAb files to sell 21.25M shares of common stock for holders - MSN
OmniAb (OABI) Stock Analysis: Undervalued or Overpriced | Q4 2025: EPS Misses ViewsDividend Report - Cổng thông tin điện tử tỉnh Lào Cai
Bullish OmniAb Insiders Loaded Up On US$1.28m Of Stock - Yahoo Finance
OABI Directors Sell $168M Stock: Gotwals, Crouse Dispose RSUs April 22 - Meyka
OmniAb (OABI) well-positioned for momentum build-up in 2026 - MSN
OmniAb to Report First Quarter 2026 Financial Results on May 7 - BioSpace
Stifel reiterates Buy rating on OmniAb stock, cites partner growth - Investing.com
OmniAb, Inc. (NASDAQ:OABI) Q3 2025 Earnings Call Transcript - MSN
OmniAb, Inc. (OABIW) - Minichart
OmniAb (OABI) Stock Downside Risk (Spikes) 2026-04-16Verified Analyst Reports - Cổng thông tin điện tử tỉnh Lào Cai
Biotech Penny Stocks Rally OABI ABCL PACB 2026 - Gotrade
EBITDA per share of OmniAb, Inc. – NASDAQ:OABIW - TradingView
Working capital per share of OmniAb, Inc. – NASDAQ:OABIW - TradingView
Free cash flow per share of OmniAb, Inc. – NASDAQ:OABIW - TradingView
Net current asset value per share of OmniAb, Inc. – NASDAQ:OABIW - TradingView — Track All Markets
OmniAb (OABI) Well-Positioned for Momentum Build-Up in 2026 - Yahoo Finance
Trade Report: Is Clearwater Paper Corporation attractive for institutional investorsQuarterly Growth Report & Weekly High Conviction Ideas - baoquankhu1.vn
Buy Signal: How correlated is OmniAb Inc to the S P5002026 Price Momentum & Smart Investment Allocation Insights - baoquankhu1.vn
OmniAb CFO Kurt Gustafson sells $10,300 in shares By Investing.com - Investing.com Canada
OmniAb director Foehr sells $29k in shares By Investing.com - Investing.com Canada
OmniAb (OABI) chief legal officer Berkman sells $10,663 in stock By Investing.com - Investing.com Canada
What is happening with OmniAb (OABI) Stock right now | Price at $1.51, Down 1.95%Stock Trading Network - Newser
OmniAb CFO Sells Over $10,000 in Shares - National Today
OmniAb (NASDAQ:OABI) CEO Matthew Foehr Sells 19,244 Shares - MarketBeat
OmniAb (NASDAQ:OABI) Insider Sells $10,663.93 in Stock - MarketBeat
OmniAb (OABI) chief legal officer Berkman sells $10,663 in stock - Investing.com
OmniAb director Foehr sells $29k in shares - Investing.com
OmniAb CFO Kurt Gustafson sells $10,300 in shares - Investing.com
Is OmniAb (OABI) Stock Attractive Now | Price at $1.54, Up 0.32%Verified Analyst Reports - Newser
OABI Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Leerink reiterates Outperform on OmniAb stock, $10 target By Investing.com - Investing.com Australia
Leerink reiterates Outperform on OmniAb stock after partner trial fails - Investing.com UK
Leerink reiterates Outperform on OmniAb stock, $10 target - Investing.com UK
Omniab Inc Stock (OABI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):